Morris J. Brown

2 ta ish

William Harvey Research Institute

1. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

   Bryan Williams, Thomas M. MacDonald, S. V. Morant +10

   MaqolaOAOchiq kirish20153 iqtibos

   ABIABI:AkademIndex/2026.other.211224

2. Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double‐Blind Randomized Controlled Trial

   Thomas M. MacDonald, Bryan Williams, David J. Webb +12

   Maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.295839